Skip to main content
OpenTrials
Completed

NCT Number: NCT07504224

ASD Wearables Feasibility Study

The goal of this clinical study is to evaluate and compare the feasibility of wearable device use among pediatric participants with autism spectrum disorder (ASD) across four different wearable device form factors: a wristband, headband, adhesive patch, and finger ring. Rather than investigating health or clinical outcomes associated with wearable device use, the study focuses on comparative assessment of device types to determine which forms are most acceptable and practical for this population.

The study explores factors that may influence feasibility, including comfort, wearability, sustained use, and participant and caregiver engagement. The main questions the study aims to answer are:

* Were adolescents with ASD able to tolerate wearing the assigned device for the full two-week study period? * Did adolescents with ASD and their caregivers consider the wearable device to be comfortable and usable? * Were there any unanticipated factors that affected the feasibility of wearable device use among youth with ASD?

Researchers will compare data collected across device groups to determine (1) which form factor performed most effectively in real-world settings, and (2) which design characteristics are most important to consider when developing or selecting wearable devices intended for safe, acceptable, and sustained use in adolescent ASD populations.

Adolescent participants and their caregivers will:

* Be asked to complete four research visits (two in-person and two virtual video visits) * Complete multiple questionnaires (caregivers), assessments (adolescents) and two semi-structured interviews * Wear the assigned wearable device, as instructed, for a two-week trial: either a headband, wristband, adhesive patch, or finger ring

Completed

Looking for future studies?

Notify Me

Key information

Age range

13 year–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Rady Children's Hospital, San Diego

San Diego, California, 92123, United States

About this study

Wearable devices are increasingly used to support clinical research and caregiver decision-making; however, individuals with autism spectrum disorder (ASD) may experience unique challenges related to wearable device use. Sensory sensitivities and responses to physical stimuli may affect the tolerability, comfort, and sustained use of wearable technologies in this population. As a result, understanding how adolescents with ASD interact with and perceive different wearable device designs is an important step in selecting and developing devices suitable for real-world use.

This clinical study is a comparative evaluation of wearable device use across four different device form factors-a wristband, headband, adhesive patch, and finger ring-under real-world conditions in adolescents with ASD. The study examines feasibility-related factors, including device tolerability, comfort, usability, and wearability over a two-week study period. Participants are assigned to a single device type, and data are collected to assess their experiences using the assigned wearable during daily activities.

Rather than focusing on physiological mechanisms or evaluating clinical or health outcomes, this study is designed to generate comparative information on how different wearable device designs are experienced by pediatric participants with ASD. Findings from this study are intended to inform future research, development, and selection of wearable technologies that are acceptable, practical, and suitable for use in adolescent ASD populations.

Event Overview:

Study Visit #1: Day 1 (90 min)

  • Virtual e-consent for adolescent and caregiver assent and consent
  • Virtual semi-structured interview #1
  • Device assignment

Study Visit #2: Day 2 (60 minutes)

  • In person participant assessment
  • NIH toolbox V2 Cognitive & Emotional Assessment Batteries
  • In person caregiver assessments:
  • Short Sensory Profile-2 (SSP-2)
  • Social Responsiveness Scale (SRS-2)
  • Child Behavior Checklist (CBCL)
  • Medical history questionnaire
  • Receive allocated device assignment
  • Priming: Social Story - Participants will be introduced to their wearable device via a social story to prepare them to better understand and manage their involvement in the study.
  • 1st $25 compensation installment

Days 3-16

  • Adolescent will wear the wearable device for 2 weeks
  • During the two weeks, usage will be tracked by a researcher who may contact participants to intervene if no data are being collected

Study Visit #3: Day 17

  • Virtual semi-structured interview #2
  • Caregiver assessments
  • System Usability Scale (SUS)
  • Comfort Rating Scale (CRS)

Study Visit #4: Day 18

  • Return device to study
  • 2nd $25 compensation installment

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Provision of signed and dated informed consent and assent forms
  • Stated willingness to comply with all study procedures
  • Stated availability for the duration of the study
  • Parent provided diagnosis of autism spectrum disorder confirmed via formalized assessment

Exclusion criteria

  • Presence of acute psychiatric symptoms, such as:
  • Suicidal ideation (SI)
  • Homicidal ideation (HI) During the prescreening call, the researcher will ask the prospective adolescent participant, "Do you have thoughts of harming yourself or others?" and if yes, the researcher will contact the PI and contact 911 depending on acuity of situation.

Treatment and study plan

14-Day Device Monitoring

Device

Adolescents will receive a wearable device, of the form factor device group (wristband, headband, adhesive patch, ring) they were sequentially assigned to at enrollment, to wear for a consecutive period of 14 days. Participants will be asked to go about their daily life normally with awareness of the wearable device requirements and limits specific to their assigned study arm. Researchers will remotely monitor the data collected by these wearable devices and intervene during this two-week trial if no data is being obtained.

Primary outcomes

  1. Device Wear Adherence (Data Completeness)

    Time frame: 2 weeks

    A device-specific data completeness score will be calculated for each participant as a measure of adherence to the device wear protocol. Completeness is defined as the percentage of expected wear time during which valid device data were successfully recorded. Expected daily wear duration was defined as 24 hours for the wristband and adhesive patch, and 8 hours for the headband and finger ring. For devices with an 8-hour expected wear period, days with 8 or more hours of valid data were considered 100% complete. Completeness scores will be summarized by device type to compare adherence across wearable form factors.

Secondary outcomes

  1. Device Wear Adherence (Complete Expected Periods)

    Time frame: 2 weeks

    To account for differences in expected period of device wear (night-only vs continuous) Complete Expected Periods is effectively a discretized version of Completeness that segments time into Day and Night periods.

    Day Period: A 14-hour window from 08:00 to 22:00. Night Period: A 10-hour window from 22:00 to 08:00. A given period was considered "complete" if the number of minutes that contained valid data exceeded a common threshold for data inclusion. This corresponded to 600 minutes (10 hours) of data for the day period, and 360 minutes (6 hours) for the night period. For the headband and ring, only night periods were expected, so 6 hours of data over a 24-hour period (12pm-12pm) was considered "complete".

  2. Device Comfort

    Time frame: 2 weeks

    The Comfort Rating Scale (CRS; Knight et al., 2002) will be used to measure adolescent and caregiver perceptions of the comfortability of the assigned wearable device. Scores are aggregated to identify specific aspects of the device that may cause discomfort, facilitating targeted design improvements for wearable systems.

  3. Device Usability

    Time frame: 2 weeks

    The System Usability Scale (SUS; Brooke, 1996) will be used to measure adolescent and caregiver perceptions of the usability of each device and corresponding data capturing system. To calculate the SUS score, individual item scores are transformed and summed to produce a single value ranging from 0 to 100. This score represents a composite measure of the overall usability of the system being studied.

Other outcomes

  1. Qualitative Responses: Adolescent and Caregiver Feedback

    Time frame: 2 weeks

    Qualitative feedback from post-device interviews with participants and caregivers will be collected to explore experiences with wearable device use, including perceptions of overall benefits, challenges, and mental health impact associated with wearing the device for two-weeks. Responses will be analyzed descriptively to identify common themes related to feasibility of wearable device use in adolescents with ASD.

Sponsors and collaborators

Lead sponsor

Rady Pediatric Genomics & Systems Medicine Institute

Other

Collaborators

  • Rady Children's Hospital, San Diego
  • University of California, San Diego

Registry information

Official study title

Feasibility of Wearable Devices as a Source of Data to Support HealthAI in Autism Spectrum Disorder Populations

Acronym: ASDW

Important dates

Study start
2024
Primary completion
2025
Study completion
2026
First posted
Mar 31, 2026
Registry last updated
Apr 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.